07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Incubation of rat cortical neurons <strong>for</strong> 24 h at 37°C in a serumless medium containing veratridine<br />

(30 κM) resulted in a significant increase in cell death. NW-3381, added 1 h be<strong>for</strong>e veratridine,<br />

was able to reduce the neuronal damage with an IC50 = 6 κM.<br />

Our results show that NW-3381 by functionally blocking the consequences of Na + channel<br />

activation (both the Na + influx and the subsequent Ca 2+ influx due to the prolonged<br />

depolarization) might have a potential <strong>for</strong> neuroprotection.<br />

Disclosures: P. Salvati, None; L. Curatolo, None; A. Restivo, None; C. Sabido-david,<br />

None; S. Francisconi, None; C. Caccia, None.<br />

Poster<br />

235. Ion Channels in Disease I<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 235.6/C52<br />

Topic: B.04.d. Ion channels and disease<br />

Support: 6TH FRAMEWORK EUROPEAN PROGRAM<br />

<strong>Title</strong>: Antiepileptic properties and antipsychotic potential of NW-3381, a novel potent sodium<br />

channel blocker<br />

Authors: E. IZZO 1 , M. CALABRESI 1 , *C. SABIDO-DAVID 1 , S. PARINI 1 , A. VEZZANI 2 , M.<br />

CARLI 2 , S. BALOSSO 2 , K. WEDZONY 3 , P. SALVATI 1 ;<br />

1 Newron Pharmaceut SPA, Bresso, Italy; 2 MARIO NEGRI INSTITUTE, MILANO, Italy;<br />

3 Polish Acad. of Sci., KRAKOW, Poland<br />

<strong>Abstract</strong>: Sodium channels have been implicated in a number of diseases including epilepsy,<br />

pain and psychiatric disorders. Several drugs in the market targeting sodium channels have<br />

shown to be effective against these diseases. NW-3381 was selected <strong>for</strong> its high potency (submicromolar<br />

range) <strong>for</strong> the target (sodium channels) and good preliminary profile in terms of<br />

selectivity and developability.<br />

To assess its antiepileptic activity, NW-3381 was tested in a range of seizure models in mice: the<br />

maximal electroshock test (MES), the kainic acid (KA)-induced status epilepticus (SE), and the<br />

ip pentylenetetrazol (PTZ)-induced generalized seizures, in comparison to the antiepileptic drug<br />

lamotrigine. In the MES test the compound resulted to be active both after intraperitoneal (ip)<br />

and oral (po) treatment with ED50 of 4.6mg/kg and 8.9mg/kg respectively. In the KA model the<br />

dose of 20mg/kg po significantly inhibited seizure generalization and the incidence of SE while<br />

lamotrigine at 30mg/kg ip was ineffective. In the PTZ model NW-3381 20mg/kg ip protected<br />

from generalized seizure whereas lamotrigine at 15 and 30mg/kg ip worsened seizure severity.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!